• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

    9.150 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 520
    Open 9.150
    Bid (Size) 9.080 (20)
    Ask (Size) 9.150 (1)
    Prev. Close 9.150
    Today's Range 9.150 - 9.150
    52wk Range 4.970 - 16.75
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
    The global 
    Via Talk Markets

    Performance

    YTD
    -7.29%
    -7.29%
    1 Month
    -3.79%
    -3.79%
    3 Month
    -14.08%
    -14.08%
    6 Month
    -7.01%
    -7.01%
    1 Year
    +6.52%
    +6.52%

    More News

    Read More
    3 Stocks Under $10 Set to Quadruple by 2025: June Edition
    Via InvestorPlace
    AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
    Via Talk Markets
    Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
    Via The Motley Fool
    How Is The Market Feeling About Recursion Pharmaceuticals?
    Via Benzinga
    Recursion Pharm Stock Sees Relative Strength Rating Rise To 84
    Via Investor's Business Daily
    Nvidia’s Golden Handshake: 3 Stocks Reaping the Rewards of an NVDA Alliance
    Via InvestorPlace
    1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
    Via The Motley Fool
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Cathie Wood Owns These 2 AI Stocks. Should You?
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Is Recursion Pharmaceuticals Stock a Millionaire-Maker?
    Via The Motley Fool
    Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
    Via The Motley Fool
    Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week
    Via Talk Markets
    Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    2 Stocks That Could 10x by 2035
    Via The Motley Fool
    Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
    Via Benzinga
    A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    What's the Difference Between Biotech Stocks and TechBio Stocks?
    Via The Motley Fool
    Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    The Next Drug You Take May be Designed By A.I.
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Recursion Pharmaceuticals Stock Surges 10% As Nvidia-Powered Supercomputer Completion Sparks Investor Optimism
    Via Benzinga
    Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
    Via Talk Markets
    Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.